PH19112A - Purine derivatives endowned with immunomodulating activity as their pharmaceutical compositions - Google Patents

Purine derivatives endowned with immunomodulating activity as their pharmaceutical compositions

Info

Publication number
PH19112A
PH19112A PH27842A PH27842A PH19112A PH 19112 A PH19112 A PH 19112A PH 27842 A PH27842 A PH 27842A PH 27842 A PH27842 A PH 27842A PH 19112 A PH19112 A PH 19112A
Authority
PH
Philippines
Prior art keywords
endowned
pharmaceutical compositions
purine derivatives
immunomodulating activity
immunomodulating
Prior art date
Application number
PH27842A
Other languages
English (en)
Inventor
Paolo Cornaglia Ferraris
Original Assignee
Co Pharma Corp Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT24120/81A external-priority patent/IT1140205B/it
Priority claimed from IT22848/82A external-priority patent/IT1152372B/it
Application filed by Co Pharma Corp Srl filed Critical Co Pharma Corp Srl
Publication of PH19112A publication Critical patent/PH19112A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH27842A 1981-09-24 1982-09-09 Purine derivatives endowned with immunomodulating activity as their pharmaceutical compositions PH19112A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT24120/81A IT1140205B (it) 1981-09-24 1981-09-24 Composti immuno-modulatori specifici, procedimento per la loro preparazone e composizioni farmaceutiche che li contengono
IT22848/82A IT1152372B (it) 1982-08-13 1982-08-13 Composti immonu-modulatori specifici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
PH19112A true PH19112A (en) 1986-01-06

Family

ID=26328276

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27842A PH19112A (en) 1981-09-24 1982-09-09 Purine derivatives endowned with immunomodulating activity as their pharmaceutical compositions

Country Status (10)

Country Link
US (1) US4567182A (fr)
EP (1) EP0077460B1 (fr)
KR (1) KR870001029B1 (fr)
AU (1) AU564576B2 (fr)
CA (1) CA1258149A (fr)
DE (1) DE3273785D1 (fr)
IN (1) IN156319B (fr)
LU (1) LU88813I2 (fr)
NL (1) NL960015I2 (fr)
PH (1) PH19112A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
IT1223604B (it) * 1987-12-24 1990-09-29 Co Pharma Corp Srl Derivati purinici ad azione farmacologica
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE68922903T2 (de) * 1988-12-19 1995-11-23 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT1244501B (it) * 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
US5559114A (en) * 1994-12-16 1996-09-24 Exley; Ray W. Treatment of autoimmune disease using 2-amino purine derivatives
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
CN100345545C (zh) * 2003-06-18 2007-10-31 中国科学院上海药物研究所 6－氨基－α(R)－羟基－9H－嘌呤－9－丁酸乙酯的免疫抑制作用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters

Also Published As

Publication number Publication date
AU8808082A (en) 1983-03-31
NL960015I1 (nl) 1996-10-01
CA1258149A (fr) 1989-08-01
KR840001575A (ko) 1984-05-07
AU564576B2 (en) 1987-08-20
US4567182A (en) 1986-01-28
KR870001029B1 (ko) 1987-05-25
EP0077460A2 (fr) 1983-04-27
LU88813I2 (fr) 1998-03-20
NL960015I2 (nl) 1998-03-02
EP0077460A3 (en) 1984-03-21
DE3273785D1 (en) 1986-11-20
IN156319B (fr) 1985-06-22
EP0077460B1 (fr) 1986-10-15

Similar Documents

Publication Publication Date Title
NZ213528A (en) Purine derivatives and pharmaceutical compositions
NZ216021A (en) Purine and 1,2,3 triazolopyrimidine derivatives and pharmaceutical compositions
ZA828797B (en) Pharmaceutical formulation
ZA824622B (en) Pharmaceutical compositions
PH19112A (en) Purine derivatives endowned with immunomodulating activity as their pharmaceutical compositions
ZA859730B (en) Pharmaceutical compositions containing new imidazo derivatives
ZA825397B (en) Pharmaceutical compositions
IL76546A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
ZA822856B (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
GB2151629B (en) Apovincaminic acid ester derivatives
IL74803A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
HUT39363A (en) Process for preparing pharmaceutical compositions with retarded activity
NZ219250A (en) Purine derivatives and pharmaceutical compositions
NZ196640A (en) Pyrimidone derivatives; pharmaceutical compositions
GB2109382B (en) Ascorbic acid derivatives
IL62696A0 (en) Pharmaceutical compositions comprising a deazapurine nucleoside
ZA845997B (en) Pharmaceutical compositions with antibiotic-immunostimulating activity
ZA857647B (en) Purine derivatives
KE3739A (en) Pharmaceutical compositions
ZW18582A1 (en) Pharmaceutical compositions
NZ199488A (en) Cephalosporinic acid derivatives
IL74881A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL64954A (en) 2-hydroxymethyl-3-hydroxy-pyridine derivatives useful as intermediates in the preparation of pirobuterol
ZA82186B (en) Pharmaceutical compositions